DMO's partner Dassault Systèmes working on Covid19 vaccine trials
In the light of recent developments, Dassault Systèmes' purchase of Medidata just over a year ago may prove to be a pure stroke of genius. The company engages in clinical trials for medical technology, and is working with the medtech company Moderna to support clinical trials of the mRNA-1273-Modernes COVID-19 vaccine candidate. On the surface, this sounds not only like a possible hit for the battle
against the coronavirus pandemic, but also as something that could have a positive commercial effect on both parties involved.